Cost effectiveness of treating eosinophilic exacerbations of asthma and COPD with benralizumab: health economic analysis of the ABRA trial - Amsterdam 2025

Airway disease exacerbations under the microscope

Chair(s): Frederik Trinkmann, Sanjay Ramakrishnan

Session type: Poster session

Cost effectiveness of treating eosinophilic exacerbations of asthma and COPD with benralizumab: health economic analysis of the ABRA trial

Sanjay Ramakrishnan

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Evaluation of Exacerbation Severity in Patients with COPD Exacerbations According to the GOLD 2023 Report: Prospective, Multicenter, Real-Life Study

Halil Ibrahim Yakar

Poster

Abstract

Cost effectiveness of treating eosinophilic exacerbations of asthma and COPD with benralizumab: health economic analysis of the ABRA trial

Sanjay Ramakrishnan

Poster

Abstract

Global differences in the epidemiology and exacerbations among patients with moderate-to-severe asthma

Anna Vichiendilokkul

Poster

Abstract

Patterns of corticosteroid use in acute exacerbations of severe asthma

Dennis Thomas

Poster

Abstract

Comparison of nebulized long-acting muscarinic antagonist (LAMA) revefenacin to short acting muscarinic antagonist (SAMA) ipratropium in COPD patients with acute respiratory failure requiring mechanical ventilation

Joanne Bando

Poster

Abstract

Ketoprofen Lysinate counteracts cigarette smoke effects in a model of airways viral infection

Paola Pinto

Poster

Abstract

Characterizing exacerbations in severe asthma patients treated with tezepelumab

Faizan Haris

Abstract

Real-world effectiveness of antibiotics in addition to oral corticosteroids for managing asthma exacerbations in adults

Irene Mommers

Poster

Abstract

Cardiovascular events and pharmacological treatment patterns in patients with severe COPD exacerbations: A US payer perspective

Ernesto Mayen

Poster

Abstract

Antibiotics in exacerbations of COPD: does current practice underline the need for a personalised approach?

Niall O'rourke

Poster

Abstract

Systemic EP4 agonist and Ariginase 1 therapy in influenza virus-induced asthma exacerbation

Saeed Kolahian

Poster

Abstract

Association between inhaled corticosteroids and mortality in critically ill patients with AECOPD: an analysis of two observational cohorts

Hai-yun Dai

Poster

Abstract

Expanded High Risk COPD Exacerbation Inclusion Criteria in a COPD Trial

João Ferreira

Poster

Abstract

Severe Asthma Exacerbation in the ICU: Our Experience at Hospital Clínic de Barcelona.

Marina Paredes

Poster

Abstract

Steroid-induced hyperglycaemia in exacerbations of COPD: supporting the case for blood eosinophil-directed treatment (BET)?

Niall O'rourke

Poster

Abstract

Patients with COPD prioritise chronic symptoms and functional impact as key outcomes in exacerbation trials

Sachin Ananth

Poster

Abstract

Effect of add-on doxofylline on symptom improvement in severe COPD exacerbation: a randomized controlled trial

Nathaorn Phuangsombut

Poster

Abstract

Pulmonary artery to aorta diameter ratio as a predicting marker of cardiovascular events in COPD

Masataka Hirai

Poster

Abstract

Assessing the Feasibility of pMDI and Jet Nebulization for Bronchodilator Delivery in AECOPD Patients on NIV: A Randomized Pilot Trial

Vishal Raj

Poster

Abstract

Multidimensional classification for severity of exacerbations of COPD: The COPD Exacerbation BAT (Baseline, Acuity, and Trigger) conceptual model

Hnin Aung

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}